Takemi Akahane

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 466 citations

Medicine, Internal Medicine, Pharmacotherapy +12

Evidence‐based clinical practice guidelines for liver cirrhosis 2020

Hitoshi Yoshiji, Sumiko Nagoshi, Takemi Akahane et al. · Hepatology Research · 2021 · 196 citations · Full text

Medicine, Internal Medicine, Nutrition +12

Leptin‐mediated neovascularization is a prerequisite for progression of nonalcoholic steatohepatitis in rats†

Mitsuteru Kitade, Hitoshi Yoshiji, Hideyuki Kojima et al. · Hepatology · 2006 · 143 citations · Full text

Medicine, Pathobiology, Pathology +17

TIMP-1 inhibits microvascular endothelial cell migration by MMP-dependent and MMP-independent mechanisms

Takemi Akahane, Manabu Akahane, Amy Shah et al. · Experimental Cell Research · 2004 · 105 citations

Life Sciences, Cell Biology, Molecular Medicine +10

Rifaximin ameliorates hepatic encephalopathy and endotoxemia without affecting the gut microbiome diversity

Kosuke Kaji, Hiroaki Takaya, Soichiro Saikawa et al. · World Journal of Gastroenterology · 2017 · 102 citations · Full text

Life Sciences, Microbiology, Pharmacology +17